tiprankstipranks
Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market

Cyclerion Therapeutics (CYCN) Ownership - Who Owns Cyclerion Therapeutics?

155 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 11, 2023
xxxxxxxxxxxxx
$27

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
357,880Institution13.21%1,184,583
41,864Institution1.54%138,570
40,531Institution1.50%134,158
32,351Institution1.19%107,082
23,490Institution0.87%77,752
16,885Institution0.62%55,889
14,015Institution0.52%46,390
5,350Institution0.20%17,709
3,789Institution0.14%12,542
209Institution<0.01%692

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
41,864Institution1.54%138,570
40,531Institution1.50%134,158
32,351Institution1.19%107,082
16,885Institution0.62%55,889
5,350Institution0.20%17,709
3,789Institution0.14%12,542
209Institution<0.01%692

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
23,490Institution0.87%53,557
14,015Institution0.52%37,420

FAQ

Who Owns Cyclerion Therapeutics,Inc. (CYCN)?
Currently, no data Available
What percentage of Cyclerion Therapeutics,Inc. (CYCN) stock is held by institutional investors?
Currently, no data Available
What percentage of Cyclerion Therapeutics,Inc. (CYCN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cyclerion Therapeutics,Inc. (CYCN)?
David Gerald Greenspan owns the most shares of Cyclerion Therapeutics,Inc. (CYCN).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis